Abstract | OBJECTIVE: STUDY DESIGN: Double-blind, placebo-controlled, 12-week trial. SUBJECTS: A total of 45 non-pregnant women with BV were enrolled in the trial. Patients were treated with MVG 2.5 g or the corresponding placebo (P) daily for the first week and then every 3 days for the following 5 weeks (treatment phase) in a 2:1 ratio. All patients were followed for an additional 6 weeks without treatments (follow-up phase). Clinical cure was defined as absence of vaginal discharge, vaginal pH <4.5, a negative fish odour test and a Nugent score <7. RESULTS: At week 6, 28 out of 30 women (93%) in the MVG group were clinically cured in comparison with only 1 out of 15 (6%) in the P group (P=0.0001). At week 12, 86% of MVG treated women remained cured in comparison with 8% in P group (P=0.0001). At baseline, the vaginal pH was 6.1+/-0.7 in the MVG and 5.5+/-0.7 in the P group. Vaginal pH significantly (P=0.003) decreased to 4.3+/-0.3 in the MVG group. In P group non-significant modifications of vaginal pH were observed (5.1+/-0.5). CONCLUSION: Our results demonstrated that this MVG is an effective treatment of BV.
|
Authors | Angelo Fiorilli, Bruno Molteni, Massimo Milani |
Journal | European journal of obstetrics, gynecology, and reproductive biology
(Eur J Obstet Gynecol Reprod Biol)
Vol. 120
Issue 2
Pg. 202-5
(Jun 01 2005)
ISSN: 0301-2115 [Print] Ireland |
PMID | 15925053
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Acrylic Resins
- Gels
- Placebos
- Polyvinyls
- Vaginal Creams, Foams, and Jellies
- carboxypolymethylene
- calcium polycarbophil
|
Topics |
- Acrylic Resins
(administration & dosage)
- Administration, Intravaginal
- Adult
- Aged
- Double-Blind Method
- Female
- Gels
- Humans
- Hydrogen-Ion Concentration
- Middle Aged
- Odorants
- Placebos
- Polyvinyls
(administration & dosage)
- Prospective Studies
- Vaginal Creams, Foams, and Jellies
(therapeutic use)
- Vaginal Discharge
- Vaginosis, Bacterial
(diagnosis, drug therapy)
|